ETFs Ipsen

IPN

FR0010259150

Name	Varia. Jan 1.	Weight	AuM
INDEXIQ FACTORS SUSTAINABLE EUROPE EQUITY UCITS ETF - EUR	+2.71%	0.43%	150 M€
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	+9.26%	0.24%	1,111 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	-0.48%	0.09%	26 M€
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	+7.14%	0.03%	32 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	+2.80%	0.02%	33,076 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	-0.69%	0.01%	399 M€
RAREVIEW SYSTEMATIC EQUITY ETF - USD	+3.96%	0%	50 M€
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	+1.50%	0%	864 M€
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	+1.41%	0%	64 M€
ADAPTIVE GROWTH OPPORTUNITIES ETF - USD	+3.78%	0%	300 M€

Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (73.7%); - neuroscience (20.6%); - rare diseases (5.7%). At the end of 2024, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide. Net sales are distributed geographically as follows: Europe (39.3%), North America (34.3%) and other (26.4%).

Employees

5,358

Sector

Pharmaceuticals

Calendar

03-03 - UBS European Conference

More about the company